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Abstract
CpG islands (CGIs) are vertebrate genomic landmarks that encompass the promoters of most genes and often lack DNA
methylation. Querying their apparent importance, the number of CGIs is reported to vary widely in different species and
many do not co-localise with annotated promoters. We set out to quantify the number of CGIs in mouse and human
genomes using CXXC Affinity Purification plus deep sequencing (CAP-seq). We also asked whether CGIs not associated with
annotated transcripts share properties with those at known promoters. We found that, contrary to previous estimates, CGI
abundance in humans and mice is very similar and many are at conserved locations relative to genes. In each species CpG
density correlates positively with the degree of H3K4 trimethylation, supporting the hypothesis that these two properties
are mechanistically interdependent. Approximately half of mammalian CGIs (.10,000) are ‘‘orphans’’ that are not associated
with annotated promoters. Many orphan CGIs show evidence of transcriptional initiation and dynamic expression during
development. Unlike CGIs at known promoters, orphan CGIs are frequently subject to DNA methylation during
development, and this is accompanied by loss of their active promoter features. In colorectal tumors, however, orphan CGIs
are not preferentially methylated, suggesting that cancer does not recapitulate a developmental program. Human and
mouse genomes have similar numbers of CGIs, over half of which are remote from known promoters. Orphan CGIs
nevertheless have the characteristics of functional promoters, though they are much more likely than promoter CGIs to
become methylated during development and hence lose these properties. The data indicate that orphan CGIs correspond
to previously undetected promoters whose transcriptional activity may play a functional role during development.
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Introduction
In the decade since the human genome sequence was published
[1,2], annotation of its landmarks and functional domains has been
a priority. Protein coding genes have been quite comprehensively
identified and mapped, but full annotation of the genome is far from
complete. In addition to genes, there are DNA sequence categories
of likely functional importance, including non-coding transcription
units, conserved elements and regions of variant base composition,
whose biological significance is not well understood. Into the latter
category fall CpG islands (CGIs), which comprise about 1% of the
genome and display an elevated G+C base composition spanning
approximately 1000 base pairs. Their distinguishing feature is a
high frequency of the dinucleotide CpG, but beyond this they do not
share long range sequence similarity [3]. In the human genome,
CGIs have approximately 1 CpG every 10 base pairs, which is
about 10 times more frequent than the surrounding DNA. The high
density of CpG shared by CGIs is partly explained by a G+C-rich
base composition, but also depends critically on the lack of the CpG
deficiency that is typical of the bulk genome. These dense CpG
clusters are usually devoid of CpG methylation, whereas the bulk
genome is methylated at 70–80% of CpGs. The lack of methylation
in the germline [4] means that CGIs do not suffer accelerated
mutational loss of CpGs caused by deamination of 5-methylcytosine
[5,6]. Over evolutionary time, this has given rise to the observed
contrast between a CpG-deficient bulk genome and relatively CpG-
rich CGIs. Clustering of unmethylated CpGs has allowed the CGIs
to be biochemically isolated as a relatively homogeneous fraction of
DNA [3,7] or chromatin [8].
CGIs encompass the transcription start site (TSS) of approxi-
mately 60% of human protein coding genes. Extensive genome-
wide mapping of histone modifications by chromatin immuno-
precipitation (ChIP) has established that trimethylation of lysine
4 of histone H3 (H3K4me3) is a signature mark coinciding
with most promoter CGIs, even when the associated gene is not
expressed [9–11]. A potential biological rationalisation for the
maintenance of unmethylated CpGs at many promoters has
recently emerged from studies of proteins that interact preferen-
tially with CGIs. The protein Cfp1 contains a CXXC domain that
specifically binds to CpG only when it is unmethylated and co-
localises with almost all CGIs in the mouse genome. Cfp1 is a
component of the Set1 complex which trimethylates histone H3
lysine 4 and its depletion drastically affects levels of this modi-
fication at CGIs [12–14]. Importantly, insertion of a promoterless
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stretch of CpG-rich DNA into the mouse genome is sufficient
to recruit Cfp1 and create a novel peak of H3K4me3 [14].
Complementing this predisposition to form H3K4me3 chromatin
is the intrinsic reluctance of CGIs to assemble nucleosomes [15].
Both these features appear to pre-adapt CGIs for active promoter
function.
The notion that CGIs facilitate promoter function fits well with
their presence at TSSs, but is challenged by two observations that
appear to weaken the link with genes. Firstly, genomic analysis has
indicated that the number of CGIs in humans and mice is very
different, with mice apparently possessing little more than half the
number present in humans [16,17]. Lack of evolutionary
conservation would argue against a central role in promoter
function. A second reason to query the importance of CGIs has
come from the use of CXXC Affinity Purification (CAP) to identify
a large fraction of CGIs. Mapping showed that many CGIs in the
human genome are not coincident with annotated promoters, but
are either intergenic or within the body of coding regions (intragenic)
[7]. To clarify these issues we have compiled a comprehensive CGI
map for three developmentally distinct human and mouse tissues
(sperm, whole blood and cerebellum). The results show that, con-
trary to previous conclusions, the numbers of CGIs in human and
mouse are very similar. Moreover, in both organisms approximately
half of all CGIs are remote from annotated promoters. These
‘‘orphan’’ CGIs co-localise with peaks of H3K4me3 and evidence
suggests that a large proportion recruit RNA polymerase II
(RNAPII) and give rise to novel transcripts. We find that de novo
methylation during development predominantly affects orphan
CGIs in both humans and mice, with few protein-coding gene
promoters being methylated. This contrasts with the situation in
colorectal tumors, where cancer-specific de novo methylation affects
both CGI categories equally, with a strong preference for those
marked in ES (embryonic stem) cells by H3K27me3 – the chromatin
modification that is associated with polycomb-mediated repression
[18–21]. Our findings sustain the notion that all CGIs correspond
with promoters and that many orphan CGIs are associated with
novel transcripts that may have regulatory significance.
Results
Similar abundance and distribution of CpG islands in
human and mouse
CGIs are characteristic of most human and mouse gene pro-
moters, but biochemical and computational studies have suggested
that the total number in the mouse genome is over one third less
than for human [16,17]. To check this observation we compre-
hensively mapped all human and mouse CGIs using CAP to
enrich for DNA fragments containing clusters of unmethylated
CpGs, in conjunction with high throughput sequencing (CAP-seq)
[7]. DNAs from three developmentally distinct tissues, sperm
(germline), blood (mesoderm) and cerebellum (ectoderm) were
studied. Initial CAP-seq analysis appeared to confirm the lower
number of CGIs in mice, but closer examination of syntenic
chromosomal regions indicated that the mouse harboured CpG-
rich regions that were not efficiently recovered under our CAP
conditions (Figure S1A). Bisulfite sequencing established that these
regions were in fact unmethylated in the mouse genome and do
therefore correspond to potential CGIs (Figure S1B). As the CpG
density of the entire mouse CGI set was found to be lower than in
human (p-value ,2.2610216; Welch Two Sample t-test; Figure
S1C), we concluded that the salt-wash conditions prior to CAP
elution were too stringent to allow retrieval of relatively CpG-
deficient mouse CGIs. Reduction from 600 mM to 560 mM NaCl
corrected this disparity and generated prominent sequence read
peaks with minimal intervening background (Figure 1 and Figure
S1D). This optimisation resulted in the identification of an
additional 7,638 CGIs in mouse which were missed under the
more stringent CAP conditions (an increase of ,50%). Applica-
tion of the lower stringency wash conditions to CAP of human
sperm DNA, however, only identified a further 179 additional
CGIs (an increase of 0.7%), indicating that virtually all human
CGIs were captured under the previous conditions. (data not
shown).
To assess the integrity of the CAP-seq data we compared the
average sequence coverage for contiguous 1 kb windows across the
whole mouse genome in a panel of CAP purified samples. Figure
S2 depicts pairwise comparisons of mouse sperm, blood and
cerebellum and includes technical replicates for sperm and
cerebellum. The strong correlation between technical replicates
indicates that the variance observed between tissues represents
bona fide biological differences (Figure S2). The similarity of CAP-
seq profiles highlights the constitutively hypomethylated state of
most CGIs irrespective of the tested tissue (Figure 1A and 1B and
Figure S2). By combining regions of substantial CAP-seq
enrichment in each tissue (see Materials and Methods) we
identified nearly equivalent CGI compliments of 25,495 and
23,021 CGIs in human and mouse, respectively. In the case of
human CGIs, these findings are similar to the results from DNA
sequence-based prediction methods, which indicated 27,000
CGIs. In mice, however, previous estimates were much lower at
15,500 than those generated by CAP (Figure 2A) [17]. This
discrepancy is probably due to the lower average CpG-richness of
mouse CGIs compared with human CGIs, as confirmed by CpG
density plots (p-value ,2.2610216; Welch Two Sample t-test;
Figure 2B). About one fifth of mouse CGIs failed to meet the
minimum bioinformatic criterion for CpG density (CpG o/e = 0.6;
dashed black line; [17], although they were significantly more CpG-
rich than bulk genomic DNA (CpG o/e in human =0.21; dashed
red line).
The compositional difference between human and mouse CGIs
was apparent when CAP-seq profiles at regions of conserved synteny
were compared. As shown in Figure 2C, two mouse CGIs at
positions conserved in human and mouse (red arrows) failed to meet
the standard sequence criteria employed by most prediction
algorithms [17,22]. It is noteworthy that other regions within these
loci approach the CpG density of CGIs, but are not retained by CAP
because they are methylated (confirmed by methylation analysis - see
below). CAP-seq, which relies on clustering of unmethylated CpGs,
Author Summary
In the decade since the sequence of the human genome
was announced, efforts have been made to annotate all
genes with their regulatory sequences. CpG islands are
short regions containing the sequence CG at high density
that map to regions controlling the expression of most
human genes (known as promoters). Using a biochemical
method, we have identified and mapped all CpG islands in
the human and mouse genomes and find that over half are
remote from known gene promoters—so-called ‘‘orphans.’’
Mice, which were thought to possess far fewer CpG islands
than humans, turn out to have a very similar number.
Surprisingly, orphan CpG islands in both species often mark
hitherto unknown promoters. The activity of these novel
promoters is particularly dynamic during normal develop-
ment, as they are often silenced by DNA methylation. In
colorectal cancers, however, aberrant DNA methylation
affects all CpG islands equally.
Orphan CpG Islands Identify Novel Promoters
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is evidently a more accurate assay for CGIs than bioinformatic
methods that do not take into account CpG methylation status.
We next determined the location of human andmouse CGIs with
respect to annotated genes. Approximately half (12,278 in human
and 11,932 in mouse) mapped to annotated gene promoters, the
remainder being evenly distributed between intra- and intergenic
regions (black asterisks in Figure 2C; see also Figure 1 and
Figure 2D). We provisionally refer to CGIs remote from annotated
promoters as ‘‘orphan-CGIs’’, pending a more complete under-
standing of their roles. Comparison of the sequence composition of
annotated promoter CGIs and orphans showed a slightly reduced
CpG density in the latter, although the difference compared to bulk
genomic DNA remained large (Figure 2E). Taking the data
together, we conclude that, while human and mouse CGIs are
compositionally distinct, their abundance and genomic distributions
are largely equivalent.
Many orphan CGIs have promoter-like characteristics
The majority of annotated CGI promoters are highly enriched
for both di- and tri-methylated H3K4 in mouse ES cells
[11,23,24]. To determine if this characteristic is shared by orphan
CGIs, we compared the H3K4me3 profile of ES cells with that of
CGIs in human and mouse. Sequence reads for both CGIs (blue)
and H3K4me3 (green) illustrate the tight association between
these marks, including intergenic and intragenic orphan CGIs in
each species (Figure 3A and B). To assess this phenomenon
globally we intersected CGIs with peaks of H3K4me3 (see
Materials and Methods). Consistent with previous reports, over
90% of annotated promoter-associated CGIs in mouse and human
ES cells coincide with peaks of H3K4me3 [11,23]. In addition,
about 40% of inter- and intragenic orphan CGIs are associated
with H3K4me3 peaks in both species (Figure 3C).
It has been reported that clusters of unmethylated CpG can
recruit H3K4me3, a modification associated with sites of tran-
scriptional initiation, via the CpG binding protein Cfp1 [14].
Consistent with these findings we confirmed that the majority
of H3K4me3 enriched loci map to CGIs in human and mouse
ES cells (74.6 and 84.1% respectively). Based on this result we
postulated that the magnitude of H3K4me3 modification may
mirror the CpG density at hypomethylated CGIs. Analysis of
CGIs, binned according to CpG density, revealed a striking
correlation between CpG density and H3K4me3 abundance in
mouse and human ES cells (Figures 3D and 3E and Figure S3).
The direct relationship between CpG density and H3K4me3
provides support for the notion that CpG plays a causal role in
attracting this chromatin mark. Separate analysis of annotated
promoter and orphan CGIs confirmed this relationship for both
classes (Figure 3E). Visual inspection suggests that many CpG-
deficient orphans which score as H3K4me3-negative possess this
modification at levels below the detection limit of ChIP-seq.
Figure 1. Typical CAP-seq profiles for human and mouse tissues. (A, B) CAP-seq read density profiles (blue) for sperm, blood and cerebellum
of human chr17: 43,061,000–43,596,500 (A) and mouse chr1: 136,095,000–136,630,500 (B). Genes (Refseq) are annotated below the CAP-seq profiles
with those mapped to the positive and negative strand displayed above and below the chromosome (grey line) respectively. Non-promoter CGIs are
denoted by asterisks. See also Figure S1.
doi:10.1371/journal.pgen.1001134.g001
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Figure 2. Similar numbers of CGIs in humans and mice, but differing CpG densities. (A) Numbers of human (pink) and mouse (black) CGIs
identified by CAP-seq (CAP) and sequence based prediction (Predicted) [17]. Total numbers are noted above each bar. (B) Histogram depicting the
CpG observed/expected (o/e) values for all human (pink) and mouse (black) CGIs. Statistical significance (**) was determined using a Welch Two
Sample t-Test. The human genome average CpG o/e value of 0.21 (broken red line) and the standard CGI prediction threshold minimum of 0.6
(broken black line) are indicated. (C) CAP-seq (blue) and CpG o/e (black; 400 bp window with a 10 bp slide) profiles for syntenic regions of human
(chr16: 16,933,500–17,785,000) and mouse (chr3: 88,960,000–88,995,000) genomes. CGIs missed by standard sequence prediction parameters in
mouse are indicated (red arrows). Sequence profiles are displayed as for Figure 1. (D) Categorisation of CGIs with respect to annotated genes (Refseq)
in human and mouse. Categories indicated are human and mouse annotated transcription start site associated (h/m-ATSS), human and mouse
intragenic (h/m-Intra) and human and mouse intergenic (h/m-Inter). (E) Box plots representing the relative CpG o/e values of CGIs at different
Orphan CpG Islands Identify Novel Promoters
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Do orphan CGIs represent previously un-annotated promoters?
Earlier studies identified unforeseen transcripts originating from
orphan CGIs located within the bodies of protein-coding genes [25–
27]. At a more global level, intergenic sites of H3K4me3 have been
linked with conserved ncRNAs [28,29]. To test whether orphan CGIs
mark unanticipated sites of transcriptional initiation we mapped sites
of RNAPII recruitment in ES cells using ChIP-seq with an antibody
specific for the hypo-phosphorylated (initiating) form [30]. Approx-
imately 21% of human orphan CGIs were associated with RNAPII
peaks, pointing to promoter activity in this cell type (Figure 4A). To
further test for transcription from orphan CGIs, we compared their
localisation with published datasets relating to gene prediction and
Figure 3. Trimethylated H3K4 is the signature chromatin mark at CGIs and is grossly proportional to CpG density. (A, B) Sequence
read profiles for H3K4me3 in ES cells (green) and CAP-seq in sperm (blue) are depicted for human chr17: 7,054,500–7,203,500 (A) and mouse chr10:
80,726,000–80,874,000 (B). (C) Bar plot indicating the percentage (displayed within each bar) of H3K4me3 positive CGIs in human (pink) and mouse
(black). Categories of CGI position relative to genes are represented as for Figure 2E. (D) Box plots of H3K4me3 reads per base (averaged across
500 bp with a 100 bp slide) spanning 5 kb surrounding all mouse CGIs at the following CpG densities (CpGs per 100 bp): ,5, 5–6, 6–7, 7–8, 8–9 and
.9, in ascending order from the top. Box plots represent the distribution of the central 50% of the data (filled box) and the median (black bisecting
line). The numbers of islands in each category (n) is noted in parenthesis. Figure S3 shows equivalent data for human CGIs. (E) Summary plot relating
the CpG density of each bin to the mean H3K4me3 read value for the central 2 kb of regions displayed in (D). Plots illustrate the relationship for all
CGIs (green) and orphan CGIs (blue).
doi:10.1371/journal.pgen.1001134.g003
genomic locations with respect to genes in human (pink) and mouse (black). Genome average and CGI prediction threshold CpG o/e values are
indicated as in (B). CGIs distribution was categorised as either annotated transcription start site (ATSS), intragenic (Intra) or intergenic (Inter). Box plots
represent the central 50% of the data (filled box), the median value (central bisecting line) and the whiskers (1.56 the inter-quartile range).
doi:10.1371/journal.pgen.1001134.g002
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RNA sequencing. For gene prediction we extracted alternative gene
sets hosted by the Ensembl and USCS genome browsers (Figure 4A)
[31,32].Mapped RNAwas assessed using published datasets based on
nuclear run on (NRO) and Cap Analysis of Gene Expression (CAGE)
[33,34]. NRO provides a ‘snap shot’ of all nascent RNA in the
nucleus by the controlled incorporation of BrU and immunoprecip-
itation with an antibody against the modified base. NRO-seq in
human lung fibroblast cells revealed transcriptional profiles with
prominent peaks corresponding to TSSs (as illustrated for ZNF557
and TTLL1; Figure 4B) [34]. CAGE is an independent RNA-based
approach which uses methylguanosine cap capture to generate short
sequence tags corresponding to the 59 termini of mature RNAs.
CAGE tags generated by deep sequencing of a panel of 12 embryonic
and somatic cell types was compared to the human CGI set
(Figure 4A) [33]. Each type of dataset implicated a partially
overlapping subset of orphan islands in transcription initiation
(Figure 4A). Altogether 42% of human orphan CGIs showed
evidence for promoter activity by one or more of these criteria. If
the presence of a coincident peak of H3K4me3 is included as a
marker of promoter function, this proportion increases to 60%
(Figure 4A). For example, two intergenic orphan CGIs that are
H3K4me3 positive and coincide with sites of RNAPII, NRO and
CAGE enrichment are shown in Figure 4B (black asterisks).
To determine if orphan CGIs have tissue specific promoter
activity we compared sites of RNAPII occupancy in mouse brain
[14] and ES cells. In total, 2,227 (20%) orphan CGIs displayed
enrichment for RNAPII in both tissues, with an additional 2,624
(23.7%) being specific to only one tissue (Figure 4C; orphans with
tissue specific RNAPII association are indicated by red and blue
lines). It is interesting to note that RNAPII occupancy at CGIs
associated with annotated promoters display an 87% overlap,
whereas coincidence between the two tissues drops to 46% at
orphan CGIs. This suggests that orphans display a more tissue
restricted expression profile than do annotated promoters as
exemplified in Figure 4D. We propose that the absence of
promoter signatures at about half of orphan CGIs probably
reflects the relatively small number of tissues tested so far. Analysis
of additional tissues would likely identify additional novel
promoters. Indeed, most or all orphan CGIs may correspond to
previously unidentified sites of transcriptional initiation.
Reciprocal screening identifies preferential methylation
of orphan CGIs
Although the majority of CGIs are unmethylated, a significant
fraction becomes methylated in somatic cells [4,7]. We used MBD
(methyl-binding domain) affinity purification (MAP; [3,7]) to
establish the patterns of DNA methylation associated with orphan
and annotated promoter CGIs in the same human and mouse
tissues that were used for CAP. DNA from each tissue was MAP-
selected to enrich DNA sequences with more than 1 methyl-CpG
per 100 bp (Figure S4). MAP and CAP data generated reciprocal
maps of methylated and unmethylated CGIs respectively. Where
MAP-seq signal was high, we observed a reciprocal depletion
of the CAP-seq profile as determined by pairwise scatter plots
(Figure S5) and illustrated for a CGI located within the HAPLN4
gene (Figure 5A). Comprehensive genome-wide analysis showed
that human and mouse methylate almost identical proportions of
CGIs in the two somatic tissues (10.6 and 10.7% respectively;
Figure 5B). Both species show a strong preference for methylating
orphan CGIs, with intragenic CGIs being even more likely than
intergenic CGIs to be methylated (21–26% compared with 13–
15%). By contrast, relatively few annotated promoter CGIs
become methylated (2.8 and 2.4% in human and mouse
respectively), as noted previously (Figure 5B) [7,35].
To determine if DNA methylation at orphan CGIs has been
conserved over evolutionary time between mice and humans, we
identified CGIs associated with single-copy orthologous genes and
examined their methylation status. We mapped all human
methylated CGIs to their orthologous sequences in mouse and
determined their methylation status in mouse blood and cerebel-
lum. This analysis showed considerable inter-species conservation as
40% of annotated promoter CGIs and 64% of intragenic orphan
CGI were methylated in mice at locations orthologous to the human
methylated CGIs (Figure 5C). Intergenic orphans CGIs were not
assessed due to difficulties in unambiguously mapping syntenic
regions lacking annotated genes. The results demonstrate conser-
vation of CGImethylation even at sites distal to gene promoters. For
example, Figure 5D and E shows a cluster of orphan CGIs located
within the HOXA locus that exhibits a closely related pattern of
blood-specific DNA methylation in each species.
There is extensive evidence that CGI methylation inhibits
transcriptional activity when coincident with gene promoters
[36,37]. To determine the effect of methylation at orphan CGIs,
we compared published H3K4me3 and RNAPII ChIP-seq data
from mouse brain [14] with methylated and unmethylated sets.
Unmethylated orphan CGIs were associated with both H3K4me3
and RNAPII, whereas methylated CGIs detected by MAP lacked
both H3K4me3 and RNAPII (Figure 6A). As CGIs are generally
unmethylated in both sperm and ES cells [4,24], we compared
sperm CAP and MAP profiles with data from ES cell chromatin.
An orphan CGI downstream of the Mett12 gene was shown to be
associated with RNAPII and H3K4me3 in ES cells but not in
brain where the orphan CGI is heavily methylated (Figure 6B;
black asterisk). Given the frequent association between orphan
CGIs and novel TSSs, these data indicate that DNA methylation
correlates with transcriptional silencing at these loci.
Orphan CGIs are not preferentially methylated in
colorectal carcinomas
Silencing of tumour suppressor genes by unscheduled de novo
methylation of their promoter CGIs has been proposed as a
primary event leading to unchecked proliferation in neoplastic
cells [38–41]. Do the sites methylated in cancer represent disease-
specific events or do they recapitulate CGI methylation seen
during normal development [39]? To address this question, we
performed MAP-seq on DNA from ten primary biopsy samples
comprising matched colon mucosa (C3,C5,C6,C9 and C10) and
colorectal cancer tumors (T3,T5,T6,T9 and T10). MAP-seq
profiles identified 1,734 CGIs which were heavily methylated in
at least three of the five cancer biopsies but hypomethylated in all
normal mucosal samples. Separating out cancer-specific from
mucosal CGI methylation events, it was apparent that many of the
former were shared by all tumors (39%). This finding highlights
the relative homogeneity of CGI methylation in different
colorectal tumors (Figure S6). Examples at the POU4F1 and
PDX1 genes are shown (Figure 7A and Figure S7; CGIs repre-
sented as blue boxes). Tumors largely preserved the CGImethylation
profile seen in normal mucosa, but additional tumour-specific CGI
methylation differed from that in normal tissues by not being
preferentially targeted to orphans (Figure 7B). In fact the proportion
of intergenic, intragenic and annotated promoter CGIs in the
tumour-specific category were approximately equal (Figure 7B).
Therefore the novel CGI methylation events accompanying cancer
do not recapitulate those seen during normal development.
It has been reported that CGIs that are aberrantly methylated
in neoplastic cells coincide with sites targeted by polycomb in
human ES cells [42–45]. We asked if the distribution of CGI
methylation in the colonic mucosa and colorectal tumour samples
Orphan CpG Islands Identify Novel Promoters
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Figure 4. Many orphan CGIs demarcate sites of transcriptional initiation with tissue-restricted activity. (A) A heat map indicating the
association of human orphan CGIs (n = 13,217) with predicted gene TSSs (Pred’; grey; data from USCS and Ensembl), RNAPII peaks in human ES cells
(orange), nuclear run-on transcripts in human lung fibroblasts (NRO; grey; [34], transcripts detected by multiple tissue Cap Analysis of Gene
Expression (CAGE; purple bars; [33]) and H3K4me3 peaks in human ES cells (green). The percentage of overlap is noted within the plot and the
complete set of orphan CGIs which overlap a TSS by at least one of the above criteria is indicated (All; black). (B) Examples of orphan CGIs which co-
localise with signatures of transcriptional initiation. Mapped sequence reads for Sperm CAP (blue), hES H3K4me3, hES RNAPII, NRO and CAGE are
displayed for human chr19: 7,020,000–7,071,000 (left panel) and chr22: 41,721,500–41,819,500 (right panel). Sequence profiles are colour coded as in
(A). (C) Heat map depicting the association of RNAPII with orphan CGIs (n = 11,089) in mouse ES cells and brain. Orphan CGIs associated with RNAPII
only in ES cells or only in brain are indicated (red and blue lines respectively) and the total percentage expressed is indicated (dashed arrow). (D)
Profiles for sperm CAP (blue) and ES cell and brain RNAPII (orange) are depicted for mouse chr10: 62,302,000–62,435,000 showing two orphan CGIs
(asterisks) which are differentially associated with RNAPII in mouse ES cells and brain.
doi:10.1371/journal.pgen.1001134.g004
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reflects differential association with histone H3K27 trimethylation
in ES cells, a modification deposited by the Polycomb Repressive
Complex 2 (PRC2) [18–21]. Approximately 16% of all CGIs are
H3K27me3 positive in human ES cells [46] and these sites are not
over-represented among the CGIs methylated in blood, cerebel-
lum or normal colon (Figure 7C). On the other hand, 56% of
tumour-specifically methylated CGIs are derived from CGIs that
were H3K27 trimethylated in embryonic cells (Figure 7C).
Examples of embryonic H3K27me3 domains that give rise to
methylated CGIs in tumors are shown in Figures 7A and Figure
S7. These findings emphasise the distinction between tumour-
specific CGI methylation and that found in normally developing
Figure 6. Somatic methylation is incompatible with H3K4me3 and RNAPII occupancy at orphan CGIs. (A) Composite box plots showing
sequence read density for brain RNAPII (orange), brain H3K4me3 (green), cerebellum MAP (red) and cerebellum CAP (blue) in mouse. Plotted as for
Figure 3D. (B) Sequence profiles of CAP, MAP, H3K4me3 and RNAPII for mouse (chr11: 104,982,000–105,056,000) in ES cells and sperm (left panel) and
brain and cerebellum (right panel) depict the loss of RNAPII and H3K4me3 associated with a gain of DNA methylation in cerebellum. Sequence
profiles are colour coded as for (A).
doi:10.1371/journal.pgen.1001134.g006
Figure 5. Reciprocal screening identifies inter-species conservation of CGI methylation even at sites distal to annotated promoters.
(A) CAP- (blue) and MAP-seq (red) profile for human chr19: 19,218,000–19,264,000. (B) Bar plot representing the percentage of methylated CGIs at
different genomic locations for human (pink) and mouse (black). Categories are displayed as in Figure 2E and individual percentages for each are
noted within the plot. (C) Preferential methylation at CGIs whose location is evolutionarily conserved between humans and mice. Bar plot depicting
the percentage of mouse CGIs which are somatically methylated (All) compared with the percentage of CGIs with identifiable human orthologues
(conserved). The percentage of methylation (indicated within the plot) is displayed for CGIs associated with annotated transcriptional start sites
(ATSS; black) and orphan CGIs associated with gene bodies (Intragenic; grey). (D, E) Example of conserved orphan CGI methylation in the HOXA locus.
CAP- (blue) and MAP-seq (red) profiles spanning the first three genes in the HOXA locus in human (D) and mouse (E). Regions displayed are human
chr7: 27,098,000–27,128,000 and mouse chr6: 52,104,000–52,130,000.
doi:10.1371/journal.pgen.1001134.g005
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human somatic tissues and reinforce the link between polycomb
domains and tumour-specific CGI methylation. The proportions
of orphan and annotated promoter CGIs that are H3K27me3-
associated in ES cells is relatively similar (20% and 14% respectively),
accounting for the comparable numbers of tumour-specifically
methylated CGIs in each category.
Discussion
Equivalent CpG island complements in human and
mouse
In order to detect all CGIs in human and mouse tissues, we used
CXXC-affinity purification in combination with deep sequencing
to identify clusters of unmethylated CpG (CAP-seq). This protocol
has the advantage that fluctuations in base composition that can
erroneously register as CGIs using algorithmic methods are not
recovered by CAP unless they are free of CpG methylation. As the
vast majority (,99%) of genomic DNA is both CpG-deficient and
heavily methylated (70–80%), false-positive identification of CGIs
is minimal. The absence of significant background signal in CAP-
seq profiles verifies that CGIs represent a discrete fraction of the
mammalian genome that is conserved during evolution. Compu-
tational prediction methods suggest that the human genome
contains almost twice as many CGIs as mouse [17], but this
difference reflects a bias of sequence-based prediction methods due
to the somewhat lower average CpG density of mouse CGIs. In
fact humans and mice have similar numbers of CGIs (25,500 and
23,000 respectively). We found that an almost identical proportion
Figure 7. Distinct characteristics of normal and tumour-specific CGI methylation. (A) MAP-seq profiles (red) for five colon mucosa (C3, C5,
C6, C9 and C10) and five matched colorectal tumour (T3, T5, T6, T9 and T10) biopsy samples corresponding to human chr13: 78,052,000–78,123,500.
CGIs (blue bars) and sites of hES H3K27 trimethylation (hES H3K27me3; black bars; [46] are represented). See also Figure S7. (B) Bar plot representing
the percentage of autosomal CGI methylation in colon (red bars), colon and tumour (dark grey) and tumour only (light grey) relative to gene position
(categorised as for Figure 2E). (C) Bar plot indicating the percentage of all autosomal (blue) and methylated autosomal CGIs (red) which co-localise
with domains of H3K27me3 in human ES cells. Percentages and number of CGIs (n) are displayed within the plot. Tumour specific denotes CGIs that
are methylated in at least three colorectal carcinoma samples, but not in any of the normal colon samples.
doi:10.1371/journal.pgen.1001134.g007
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of gene promoters are embedded within CGIs in each species
(59% in human and 60% in mouse).
Although broadly similar, the number of CGIs in humans
exceeds that in mouse by ,2,500. Specific examples contributing
to this difference are known; for example the human a-globin gene
is CGI-associated, whereas this is replaced in mouse by a
methylated CpG-deficient promoter [47]. A recent study identified
a novel orphan CGI embedded within the transcription unit of
human Retinoblastoma (RB1) gene. This CGI, which is absent in
mouse, is an imprinted promoter that gives rise to a transcript
regulating RB1 transcription in cis [48]. Therefore despite the
relative similarity between the CGI compliments in human and
mouse there remain functionally important differences.
Active chromatin and transcriptional initiation at most
CpG islands
More than half of all CGIs in human and mouse (more than
10,000) can be classed as orphans that are remote from annotated
promoters, being either embedded within coding regions or
between transcription units. Trimethylation of H3K4, a signature
chromatin modification associated with sites of transcriptional
initiation [10], is present at over 40% of these unattached CGIs in
mouse ES cells, raising the possibility that many are unknown
promoters. Interestingly, the magnitude of H3K4me3 modifica-
tion at CGIs is directly correlated with the density of hypomethy-
lated CpG clustering. This is true at both annotated promoter
CGIs and orphans and is consistent with the observation that
artificial clusters of unmethylated CpG are sufficient to generate
novel peaks of H3K4me3 in transgenic ES cells [14].
There is evidence that CGIs are intrinsically poor substrates for
nucleosome assembly and therefore have a reduced requirement
for chromatin remodelling to induce transcription [15]. Given the
frequent association with H3K4me3 even at orphan CGIs [14], it
seems possible that all CGIs might provide a platform on which
transcriptional initiation can occur. Indeed many non-coding
transcripts, including Xist, Tsix, Air and HOTAIR, are transcribed
from CGIs embedded within or between the coding regions of
other genes [49–51]. Additionally, several thousand conserved
non-coding RNAs were identified by assessing sites of H3K4me3
juxtaposed to extended domains of H3K36me3 [28,29]. By
combining data from gene prediction annotations, sites of RNAPII
occupancy and nascent transcript mapping, we confirmed that
5548 (42%) and 4851 (44%) of orphan CGIs co-localised to sites of
transcriptional initiation in human and mouse respectively. The
different methods produced overlapping sets, but each also
revealed novel orphan promoters not seen by other methods
(Figure 4A). This variability may reflect differences in technical
sensitivity, RNA turnover or different CGI promoter usage
between cell types as illustrated in Figures 4C and 4D. In support
of the latter interpretation is the finding that many orphan CGIs
are positive for RNAPII and H3K4me3 in brain but not ES cells
(912 and 1046 respectively). Pending a comprehensive transcrip-
tional analysis of numerous embryonic and somatic tissues, it is
reasonable to assume that 42 and 44% are minimum estimates of
the number of orphan CGIs with promoter activity in human and
mouse. Based on the data so far, we propose that most or all
orphan CGIs correspond to promoters with tissue-restricted
patterns of expression. It is likely that the products of orphan
CGI promoters are non-coding RNAs, though some may
represent alternative transcription start sites of protein-coding
genes. We considered the possibility that orphan CGIs include
transcribed enhancer elements of the kind recently identified by
Kim et al (2010). This seems unlikely, however, as only 440 out of
28,004 enhancers (1.6%) map within 100 bp of orphan CGIs (data
not shown).
CGI methylation is conserved even at sites distal to
annotated gene promoters
Orphan CGIs resemble annotated promoter CGIs in their
sequence properties, promoter-like chromatin state and general
lack of DNA methylation. Their enhanced propensity to become
methylated during development, however, is distinctive. To
visualise CGI methylation, we applied the reciprocal technologies
of CXXC and MBD affinity purification to DNA from human and
mouse tissues. Using this positive-negative screen, we established
that both human and mouse methylated about 11% of all CGIs in
the somatic cell types that were tested. Strikingly, the great
majority of CGI methylation events occurring in these normal
tissues involve orphan CGIs. Annotated promoter CGIs, by
contrast, are infrequently methylated during development. Among
orphans, we found that intragenic CGIs were almost twice as likely
as intergenic CGIs to become methylated. An intriguing possibility
is that many intragenic orphans represent alternative promoters
which are utilised in a spatially or temporally restricted fashion, as
described for Pax6 [26]. The high frequency of methylation at this
sub-class of orphan CGIs may serve to regulate the expression of
such alternative transcripts. The functional significance of the
resulting transcripts is a matter of speculation, but one attractive
possibility is that they encode non-coding RNAs that are involved
in regulation of protein coding gene expression. In this case, highly
regulated expression patterns may be required to facilitate tissue-
specific programmes of gene expression.
Conservation of methylation patterns at orphan CGIs in
humans and mice, which diverged from a common ancestor
about 75 million years ago, suggests a functional role for these
putative promoters. The phenomenon is illustrated by the HOXA
locus where a conserved domain of orphan CGIs showed blood-
specific methylation in both species. This aligns with previous
suggestions that developmental genes, typified by HOX, are
enriched for methylated CGIs [7]. The functional role of CGI
methylation at these sites remains unclear. If all CGIs represent
transcription start sites, it is conceivable that methylation at these
sites may serve to repress regulatory non-coding RNAs such as
HOTAIR [49]. Consistent with this hypothesis we found that
somatic acquisition of DNA methylation correlates with a
precipitous depletion of RNAPII and the active histone modifi-
cation H3K4me3 at orphan CGIs. This suggests that orphan CGI
promoters are regulated by DNA methylation in the same manner
as for annotated CGI promoters.
Sites of CGI methylation distinguish normal and
neoplastic colon cells
In cancer, aberrant silencing of tumour suppressor genes often
coincides with the abnormal acquisition of CGI methylation
[38,39,41,42,45]. It has been proposed that such abnormal CGI
methylation is instructed by polycomb silencing, as sites of DNA
methylation in tumors are frequently trimethylated at H3K27 in
ES cells [42,43,45]. In strong support of this link, we observed a
three-fold over-representation of H3K27me3-associated CGIs
among the tumour-specifically methylated CGI complement of
malignant colorectal cancers. A link that might predispose sites of
H3K27me3 to DNA methylation has been proposed [52] yet the
mechanistic interplay between these repressive systems remains
uncertain, as polycomb repression and CGI methylation appear to
be alternative silencing mechanisms in ES cells, with little target
site overlap [23,24]. Recent evidence, however, suggests that
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breast cancer cells possess an altered PRC2 binding pattern
reminiscent of embryonic fibroblasts [53]. If this disrupted
chromatin pattern is typical of all neoplastic cells it could facilitate
direct crosstalk between sites of H3K27me3 and the DNA
methylation machinery.
Colorectal tumour-specific CGI methylation affects annotated
promoter and orphan CGIs equally. In contrast, normal colon
showed a typical somatic distribution of methylated CGIs as seen
in blood and cerebellum, whereby orphan CGIs were preferen-
tially methylated (Figure 7B). Interestingly, there was no
discernable preference for methylation of H3K27me3 sites in
these normal tissues. We conclude that abnormal CGI methylation
that has arisen in cancer is distinct from that which occurs during
development. It has been proposed that DNA methylation serves
to lock in a pseudo-pluripotent state via acquisition of DNA
methylation at CGIs subject to embryonic polycomb repression,
thereby facilitating cellular proliferation in neoplastic cells
[42,43,45]. This scenario involves methylation of CGIs not
normally regulated by this mechanism and it highlights the
distinction between developmental CGI methylation and that
associated with cancer.
Concluding remarks
Our results establish that CGIs represent a distinctive fraction of
the mammalian genome that is conserved between humans and
mice. The relationship between CpG density and degrees of
H3K4me3 supports a role for CpG in signalling a ‘‘promoter-
friendly’’ chromatin conformation. Although about half of CGIs in
both species are not previously annotated, our data suggests that
these nevertheless represent thousands of functional promoters,
often as novel genes for non-coding RNAs. In terms of
transcription and DNA methylation, expression of orphan CGI
promoters is more highly developmentally regulated than CGIs at
annotated protein-coding genes. This observation raises the
possibility that the resulting transcripts play functionally important
roles during development.
Materials and Methods
Ethics statement
Work involving the use of human post-mortem brain samples
was approved by the Lothian Research Ethical Committee (Ref.
2003/8/37). All donors consented to the use of this material for
DNA extraction and all samples were anonymized prior to DNA
extraction. DNA from normal and neoplastic colon tissues were
prepared under ethics 08/S1101/41 through the Edinburgh
Experimental Cancer Medicine Centre. All mouse work was
carried out in accordance with Home Office regulations. No
liscenced procedures were required for this work.
Preparation of human and mouse tissues
Human whole semen (n= 3; aged 24, 26 and 61), whole male
blood (n= 3; aged 24, 26 and 61) and whole female blood (n= 5)
was collected from healthy donors. Human semen was centrifuged
at 5000 g for 5 min then washed three times in PBS to yield pure
sperm. All donors consented to the use of this material for DNA
extraction and all samples were anonymized prior to DNA
extraction. Approximately 500 mg of human cerebellum was
provided for three males (aged 41, 50 and 54) and three females
(aged 44, 49 and 51) by the MRC Sudden Death Brain Bank,
Edinburgh.
Mouse blood was extracted from male (n = 9; aged 30 weeks)
and female (n = 8; aged 15 weeks) wild type C57Bl/6J mice. Testis
(n = 4) and cerebella (n = 3 for male and female) were dissected
from a subset of mice used for blood extraction. Testes were
dounce homogenised on ice in 310 mM sucrose, 3 mM MgCl2,
10 mM potassium phospahate (pH 6) and 0.05% v/v Triton X-
100 and cells were then centrifuged at 800 g for 20 min at 4uC.
Cells were resuspended in water and subjected to 3610 bursts of
sonication on ice at setting 2 with a duty cycle of 20% using a
Branson digital sonifer. Sonicated cells were then pelleted twice
through a 2 ml 1.5 M sucrose cushion at 1000 g for 30 min at
4uC. Pelleted cells were visually inspected to ensure the presence of
pure sperm heads.
DNA extraction
All human and mouse tissues were pooled prior to DNA
extraction. DNA was extracted from 10 mls of whole blood using
the Genomic-tip 500/G kit according to manufacturers instruc-
tions (Qiagen; 10262). Purified sperm cells were incubated in 6 M
guanidinium hydrochloride, 30 mM sodium citrate, 0.5% w/v
sarkosyl, 0.2 mg/ml proteinase K, 0.2 mg/ml RNase A and
0.3 M b-mercaptoethanol and incubated at 55uC for 4 hours.
DNA was isopropanol precipitated as previously described [54].
300 mg of frozen, cerebella were ground into a fine powder and
lysed as for sperm. Lysed material was then extracted once with
phenol:chloroform:isoamyl alcohol and once with isoamyl alco-
hol:chloroform and phased using MaxTract High density columns
according to manufacturers instructions (Qiagen; 129065). DNA
was then extracted from the aqueous phase by the addition of 5
volumes of isopropanol. All DNA was resuspended in 1x TE
buffer.
Cultured cells
Human Shef 4 ES cells [55] were a gift from Dr Andrew Smith
(Institute for Stem Cell Research, University of Edinburgh).
Mouse ES cells (E14 TG2a) were grown as previously described
[56].
Bisulfite sequencing
Bisulfite sequencing was performed as previously described [7].
DNA was sonicated using a Diagenode Bioruptor for 10 seconds
on high setting prior to bisulfite treatment.
DNA chromatography: MAP and CAP
MAP was performed using two sequential rounds of chroma-
tography as previously described [57]. For CAP, DNA was
prepared as for MAP-seq and recombinant CXXC was expressed
and purified as previously described [7]. To remove bacterial
DNA, 100 mg of purified CXXC was incubated at room
temperature for 90 min with 700 units of DNaseI supplemented
with 1x DNaseI reaction buffer (Fermentas; EN0521). CXXC was
bound to nickel charged sepharose beads at 50 mg/ml bead
volume (GE Healthcare; 17-0575-01). DNA was bound to the
CXXC matrix in 0.1 M NaCl containing column buffer, washed
at 600 mM NaCl or 560 mM NaCl and then eluted using buffer
containing 1 M NaCl. CAP was performed once per sample as this
generated sufficient enrichment for Solexa sequencing. Eluted
fractions were pooled, concentrated and precipitated as for MAP
[57]. A minimum of two independent technical replicates were
performed for each DNA sample.
Chromatin immunoprecipitation (ChIP)
ChIP was performed on human and mouse ES cells as
previously described [58]. For each immunoprecipitation, cross-
linked chromatin from approximately 10 million cells was
incubated with either 1.5 mg of anti-H3K4me3 (ab8580; Abcam)
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or 5 mg of anti-RNA Polymerase II (ab817; Abcam) antibodies for
16 hrs at 4uC. For each immunoprecipitation two independent
replicates were performed.
Library preparation and Illumina Solexa sequencing
MAP and CAP input DNA was ligated to solexa sequencing
adaptors prior to purification as previously described for MAP
[57]. CAP, MAP and ChIP solexa libraries were prepared as
previously described [57]. Solexa sequencing was carried out at
the Wellcome Trust Sanger Institute. Single end reads were
mapped to human and mouse reference genome builds (hg18 -
NCBI36 and mm9 - NCBIm37 respectively) using MAQ (http://
maq.sourceforge.net/). Reads with a mapping score greater or
equal to 30 where retained.
Analysis of high-throughput sequence data
Mapped solexa sequence in the form of. WIG files was
processed and analysed using a set of novel tools based on R
and perl scripts interfaced with the Galaxy server (http://main.g2.
bx.psu.edu/) [59]. Individual replicate solexa lanes were visually
inspected using the interactive genome browser [60] and
combined to generate single datasets for each biological sample.
An overview of all solexa sequencing data is provided in Table S1.
The parameters applied in each analysis step are outlined in Table
S1. They are; read height (H), length in bp (L) and gap permitted
in the length parameter (G). The gap parameter allows for small
interruptions in regions which are otherwise represented by
contiguous sequence reads.
Data normalization. Raw sequencing data was normalised
in order to make samples from the same purification directly
comparable. Like samples (i.e. all CAP) were scaled to a constant
approximating the ‘‘average’’ read number for that purification in
order to account for variable sequence depth. In the case of MAP
samples, background was removed prior to normalisation as
background reads could skew the normalisation procedure.
Parameters applied for normalisation are outlined in Table S1.
Peak-finding. Peaks of enrichment were identified using H,
L and G parameters as outlined in Table S1. Peak-finding was
calibrated for each purification to identify regions of known DNA
methylation or histone modification state. CAP-seq peak-finding
was tailored to identify hypomethylated CGIs previously
identified, however the high signal-to-noise ratio obtained meant
that varying these parameters did not greatly alter the efficiency of
CGI identification. Conversely, MAP-seq peak finding was
calibrated to identify well characterised methylated CGIs such as
those on the inactive X chromosome in females. For each data
type the parameters were kept consistent between all like sample
for both species.
Regions of CAP-seq enrichment in sperm, blood and cerebel-
lum were combined to give a comprehensive set of CGIs for both
human and mouse. For mouse CGIs, CAP-seq enriched regions
identified at both high and low stringency (see above) were
combined to account for the relative CpG deficiency of mouse
CGIs (the subset of CGIs only identified under stringent conditions
are outlined in Dataset S2). CGIs +/2100 bp were intersected
with additional genomic features such as predicted genes, domains
of H3K4me3 and RNAPII binding. Where required, published
datasets were converted to mm9 and hg18 using the liftover tool in
galaxy [59]. CGIs were classified as promoter associated, intra-
and intergenic based on their overlap +/2100 bp with Refseq
annotated genes (33,258 and 25,767 in Human and Mouse
respectively). CGIs were designated as promoter associated if they
overlapped the 59 end of an annotated gene (+/2100 bp).
Global analysis of sequence data. To determine the
relationship between technical replicates and experimental
variables, the mean read depth was calculated for every
contiguous 1 kb window in the human and mouse genomes.
Pair-wise plots were generated for each comparison of interest and
the correlation was assessed by calculating the Pearson correlation
coefficient using the ‘cor’ function in R.
Identification of differentially methylated CGIs. To
accurately identify differentially methylated CGIs, a sensitive
‘‘sliding window’’ analysis was carried out on MAP-Seq samples.
For each CGI the average number of reads per base was
calculated for a 100 bp window with a 20 bp slide. Values for each
window were then compared between sperm (hypomethylated
reference) and each of the somatic tissue samples. This gave a ratio
for each window. If both windows being compared contained less
than 4 reads this ratio was set to 1 in order to remove bias due to
small fluctuations at low read depth.
Differentially methylated CGIs were defined as those containing
9 out of 10 contiguous windows with a log2 ratio of .2. CGIs
were then scored as 21 (less methylated than sperm), 0 (same
methylation as sperm) and 1 (more methylated than sperm). These
parameters were verified using CGIs on the X chromosome which
are methylated specifically in females.
All analytical results are summarised in Datasets S1 and S2 for
human and mouse respectively. High-throughput sequencing data
have been deposited in the Gene Expression Omnibus (GEO)
under the accession number: GSE21442.
Supporting Information
Dataset S1 Summary of Human CGI data. Summary of all
analysed data with respect to Human CGIs.
Found at: doi:10.1371/journal.pgen.1001134.s001 (8.56 MB
XLS)
Dataset S2 Summary of Mouse CGI data. Summary of all
analysed data with respect to Mouse CGIs.
Found at: doi:10.1371/journal.pgen.1001134.s002 (6.47 MB
XLS)
Figure S1 Preliminary characterisation of Human and Mouse
CAP-seq results. (A) Sperm CAP-seq read density profiles (blue)
for human and mouse sperm generated by washing DNA bound
to the CXXC column with 600 mM NaCl prior to elution. CpG
density (black; 300 bp windows with a 10 bp slide) at 4 human
and mouse syntenic chromosomal locations is shown below the
read profiles. Genes (Refseq) are annotated below the CAP-seq
profiles with those mapped to the positive and negative strand
displayed above and below the chromosome (grey line)
respectively. The CpG density of 5 CpGs per 100 bp (dashed
black line) is indicated for reference. Mouse regions assessed
by bisulfite sequencing are indicated (bisulfite; grey bars). (B)
Bisulfite sequencing of four putative mouse CGI island
promoters. Open circles represent unmethylated CpG sites.
Each column represents a single PCR amplicon and horizontal
lines represent single sequenced DNA clones. Vertical strokes
represent the relative CpG position within each amplicon. (C)
Histogram depicting the CpG observed/expected (o/e) values for
all human (pink) and mouse (black) CGIs identified by CAP with
washing at 600 mM NaCl. Statistical significance (**) was
determined using a Welch Two Sample t-Test and CpG o/e
values of 0.21 (broken red line; human genome average) and 0.6
(broken black line; standard CGI prediction parameter) are
indicated. (D) Sperm CAP-seq read density profiles (blue) for
mouse sperm generated by washing with the optimised NaCl
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concentration (560 mM) in comparison with CpG density (black;
300 bp windows with a 10 bp slide).
Found at: doi:10.1371/journal.pgen.1001134.s003 (0.19 MB PDF)
Figure S2 Pairwise analysis of mouse CAP-seq data. Scatter
plots of CAP-seq data representing the mean sequence read depth
for every contiguous 1 kb window in the mouse genome. Each
pairwise comparison was assessed by calculating a Pearson
correlation coefficient, which is presented above each plot. Tissue
and replicate status for pairwise comparisons are noted above and
to the left of the plots.
Found at: doi:10.1371/journal.pgen.1001134.s004 (1.26 MB PDF)
Figure S3 Proportional relationship between CpG density and
H3K4me3 at Human CGIs. Box plots of H3K4me3 reads per
base (averaged across 500 bp with a 100 bp slide) spanning 5 kb of
all human CGIs at different CpG densities (CpGs per 100 bp).
CpG density categories applied are #5, 5–6, 6–7, 7–8, 8–9 and
.9 CpGs per 100 bp, arranged in ascending order from top to
bottom. Box plots represent the distribution of the central 50% of
the data (filled box) and the median (black bisecting line). The
numbers of islands in each category (n) is noted in parenthesis.
Found at: doi:10.1371/journal.pgen.1001134.s005 (0.04 MB PDF)
Figure S4 Characterisation of MAP enrichment. Histograms
representing the CpG density of MAP-enriched genomic loci in
human (hMAP) and mouse (mMAP). The vertical dashed red line
represents the lower tenth percentile of the data indicating that the
majority of characterised MAP enriched DNA fragments have a
CpG density of at least 1 and 1.3 CpGs per 100 bp in human and
mouse respectively.
Found at: doi:10.1371/journal.pgen.1001134.s006 (0.05 MB PDF)
Figure S5 Global scatter plots reveal a reciprocal relationship
between CAP- and MAP-seq data for human sperm, blood, and
cerebellum. Scatter plots display pairwise comparisons of CAP-
and MAP-seq data for every contiguous 1 kb window in the
human genome using normalised data for human sperm, blood
and cerebellum. Plots are represented as for Figure S2.
Found at: doi:10.1371/journal.pgen.1001134.s007 (0.12 MB PDF)
Figure S6 Pairwise comparisons of MAP-seq data reveal
consistent tumour-specific methylation. Scatter plots displaying
pairwise comparisons of MAP-seq data for every colon (C) and
colorectal tumour (T) sample screened by MAP-seq. Data
represents the mean sequence depth for every 1 kb window in
the human genome. Data is presented as for Figure S2.
Found at: doi:10.1371/journal.pgen.1001134.s008 (4.94 MB PDF)
Figure S7 Tumour-specific CGI methylation associated with
PDX1. MAP-seq profiles (red) for five colon mucosa (C3, C5, C6,
C9 and C10) and five matched colorectal tumour (T3, T5, T6, T9
and T10) biopsy samples for human chr13: 27,325,000–
27,402,000. CGIs (blue bars) and sites of hES H3K27 trimethyla-
tion (hES H3K27me3; black bars; [46] are represented).
Found at: doi:10.1371/journal.pgen.1001134.s009 (0.05 MB PDF)
Table S1 Sample information and data analysis parameters.
Summary of the sequence and analysis statistics for each biological
sample presented.
Found at: doi:10.1371/journal.pgen.1001134.s010 (0.04 MB
XLS)
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